HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Magnus Gisslen Selected Research

Magnus Gisslen Research Topics

Disease

10Inflammation (Inflammations)
04/2024 - 09/2011
8Infections
04/2024 - 11/2005
7HIV Infections (HIV Infection)
01/2022 - 11/2005
5COVID-19
04/2024 - 12/2020
5Central Nervous System Infections (Central Nervous System Infection)
01/2019 - 06/2010
5AIDS Dementia Complex
03/2011 - 05/2004
3Dementia (Dementias)
01/2021 - 03/2011
3Acquired Immunodeficiency Syndrome (AIDS)
12/2019 - 03/2007
3Encephalitis (Encephalitis, Rasmussen)
06/2010 - 12/2004
2Cognitive Dysfunction
01/2023 - 01/2021
2Neuroinflammatory Diseases
01/2022 - 01/2021
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 03/2007
2Persistent Infection
09/2014 - 09/2011
2Central Nervous System Diseases (CNS Diseases)
12/2013 - 12/2004
2Brain Injuries (Brain Injury)
06/2010 - 03/2007
1Syphilis
03/2024
1Neurosyphilis (General Paresis of the Insane)
03/2024
1Myocardial Infarction
02/2022
1Necrosis
02/2022
1Confusion (Bewilderment)
01/2022
1Ataxia (Dyssynergia)
01/2022
1Atrophy
01/2022
1Lethargy
01/2022
1Heart Injuries
01/2021
1Heart Failure
01/2021
1Disease Progression
01/2021
1Neurobehavioral Manifestations
01/2021
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
07/2019
1Neurocognitive Disorders (Clerambault Syndrome)
12/2018
1Alzheimer Disease (Alzheimer's Disease)
01/2014
1Opportunistic Infections (Opportunistic Infection)
06/2010
1Cryptococcal Meningitis
06/2010
1Retroviridae Infections (Infection, Retrovirus)
11/2005
1Leukoencephalopathies
12/2004
1Neurologic Manifestations (Neurological Manifestations)
05/2004

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2007
8NeopterinIBA
03/2024 - 03/2007
8RNA (Ribonucleic Acid)IBA
01/2021 - 11/2005
3Proteins (Proteins, Gene)FDA Link
04/2024 - 11/2005
3Immunoglobulin G (IgG)IBA
04/2024 - 01/2022
3ChemokinesIBA
03/2024 - 11/2005
3Tumor Necrosis Factor Ligand Superfamily Member 14IBA
01/2022 - 06/2007
2ProteomeIBA
04/2024 - 12/2013
2Immunoglobulin M (IgM)IBA
04/2024 - 01/2022
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 07/2019
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2004 - 05/2004
1ReaginsIBA
03/2024
1Troponin IIBA
02/2022
1TroponinIBA
02/2022
1Troponin T (Troponin T1)IBA
02/2022
1Trinitrotoluene (TNT)IBA
02/2022
1AntibodiesIBA
02/2022
1Disulfiram (Antabuse)FDA Link
01/2022
1AutoantibodiesIBA
01/2022
14- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA
01/2021
1LipopolysaccharidesIBA
01/2021
1Chloroquine (Aralen)FDA LinkGeneric
01/2021
1Blood Proteins (Serum Proteins)IBA
01/2021
1chloroquine diphosphateFDA LinkGeneric
01/2021
1Amyloid (Amyloid Fibrils)IBA
01/2021
1Peptides (Polypeptides)IBA
01/2014
1Serum AlbuminIBA
09/2011
1AlbuminsIBA
09/2011
1Antiviral Agents (Antivirals)IBA
03/2007
1Chemotactic FactorsIBA
11/2005
1Interferon-gamma (Interferon, gamma)IBA
11/2005
1Plasminogen Activators (Plasminogen Activator)IBA
12/2004
1HIV Core Protein p24IBA
12/2004

Therapy/Procedure

4Art Therapy
01/2023 - 06/2015
4Highly Active Antiretroviral Therapy (HAART)
01/2021 - 06/2010
2Therapeutics
12/2020 - 03/2007
1Critical Care (Surgical Intensive Care)
12/2020